OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
Clinical trial NCT03587038 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03587038
- Sponsor
- University of Oklahoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-03
- Primary completion
- 2020-12-23
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.